Akebia Therapeutics Inc. (NASDAQ:AKBA)’s traded shares stood at 2.93 million during the last session, with the company’s beta value hitting 0.91. At the close of
In the last trading session, 4.1 million Akebia Therapeutics Inc. (NASDAQ:AKBA) shares changed hands as the company’s beta touched 0.86. With the company’s per share
In last trading session, Akebia Therapeutics Inc. (NASDAQ:AKBA) saw 5.37 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price
Akebia Therapeutics Inc. (NASDAQ:AKBA) has a beta value of 0.87 and has seen 3.62 million shares traded in the last trading session. The company, currently
In today’s recent session, 3.1 million shares of the Akebia Therapeutics Inc. (NASDAQ:AKBA) have been traded, and its beta is 0.85. Most recently the company’s
Akebia Therapeutics Inc. (NASDAQ:AKBA)’s traded shares stood at 60.76 million during the last session, with the company’s beta value hitting 0.82. At the close of
In the last trading session, 8.42 million Akebia Therapeutics Inc. (NASDAQ:AKBA) shares changed hands as the company’s beta touched 0.81. With the company’s per share
In the last trading session, 7.85 million Akebia Therapeutics Inc. (NASDAQ:AKBA) shares changed hands as the company’s beta touched 0.80. With the company’s per share
In last trading session, Akebia Therapeutics Inc. (NASDAQ:AKBA) saw 5.16 million shares changing hands with its beta currently measuring 0.78. Company’s recent per share price
Akebia Therapeutics Inc. (NASDAQ:AKBA) has a beta value of 0.77 and has seen 13.44 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
